Vomiting

Vomiting is one of the most common and visible signs of chronic kidney disease in cats. Roughly one in four to one in three cats with clinical uremia vomit regularly, and many owners find it the most distressing symptom to watch. The good news is that vomiting in CKD cats is usually very treatable once the cause is identified, and effective medication can make a rapid and noticeable difference to how your cat feels.

This page covers why CKD cats vomit, how to recognize and describe what you are seeing, what the different types of vomit can tell you, other causes to rule out, and the treatments most likely to help.

As the kidneys lose their ability to filter waste products efficiently, those compounds build up in the bloodstream. This accumulation is called uremia, and the waste products are collectively known as uremic toxins. These toxins affect an area of the brain called the central chemoreceptor trigger zone, which lies just outside the blood-brain barrier and is highly sensitive to circulating compounds. When this zone is activated, it triggers the vomiting reflex.

Most anti-vomiting medications used in CKD cats work precisely here, blocking the receptors that uremic toxins stimulate.

A second, historically significant mechanism involves gastrin, a hormone that stimulates stomach acid production. Because the kidneys normally clear gastrin from the body, rising gastrin levels in CKD were long thought to cause excess stomach acid, leading to gastric irritation, ulcers, and vomiting. Acid-suppressing medications were for many years recommended as a first-line response to this assumption.

More recent research has challenged that picture. Studies measuring actual stomach acidity in CKD cats found no consistent evidence of hyperacidity compared to healthy cats, and post-mortem examination of CKD cats found no significant stomach ulceration or mucosal inflammation. The current evidence points to uremic toxins acting on the brain as the primary driver of vomiting in most CKD cats, rather than stomach acid attacking the stomach lining directly. Acid suppression may still have a role in some cats, particularly those with very advanced disease, but the automatic prescription of acid blockers for all CKD cats is no longer supported by the evidence.

Understanding this distinction matters in practice: if a cat’s vomiting is driven by uremia, treating the brain-level trigger with an antiemetic like maropitant or ondansetron is likely to produce a better result than an acid blocker alone.

One of the most important things you can do when describing your cat’s symptoms to your vet is distinguish between true vomiting and regurgitation. They look similar, but they have different causes and different treatments.

Vomiting involves the forceful ejection of stomach contents. You will usually see the cat’s abdomen heaving visibly in the moments before the material comes up. The cat may crouch down, produce saliva, and retch before vomiting. The vomited material has been in the stomach and is often partly digested or bile-stained.

Regurgitation happens with little or no warning and almost no abdominal effort. The cat simply lowers its head and food or fluid slides up and out. Regurgitated material has not reached the stomach and so tends to be undigested, tubular in shape, and sometimes surrounded by a coating of mucus. Common causes include eating too fast, hairballs, or a problem in the esophagus rather than the stomach.

CKD cats can have both, and hairballs that produce regurgitation more than twice a month are worth mentioning to your vet, as frequent hairball production can be a sign of inflammatory bowel disease rather than a normal occurrence.

Keeping a brief mental note of what the vomit looks like can help your vet narrow down the cause.

White or clear foam. This is one of the most classic presentations in CKD cats and often one of the first signs owners notice when kidney disease is developing. Foam forms when an empty stomach produces secretions that churn up with air. It is typically a sign of nausea and uremia rather than a specific stomach problem.

Clear or yellow liquid. A cat vomiting liquid or bile-colored fluid usually has an empty stomach. Yellow or greenish color comes from bile backing up from the small intestine. This pattern is common in CKD cats who go long periods without eating.

Water. Some CKD cats drink a large amount of water quickly, then vomit most of it back up soon afterward. This is thought to be linked to gastric irritation: the cat may drink instinctively in response to stomach discomfort, and the volume overwhelms the stomach. If your cat regularly does this, mention it to your vet.

Undigested or partly digested food. Food that has not left the stomach suggests a gastric motility problem, meaning the stomach is not moving its contents onward normally. This can occur in CKD cats and may warrant specific treatment.

Fresh red blood. Bright red blood in the vomit is always a reason to contact your vet promptly. It may indicate bleeding in the mouth, esophagus, or stomach, including from mouth ulcers, which occur in some cats with advanced uremia.

Dark material resembling coffee grounds. This indicates older, digested blood from somewhere in the upper gastrointestinal tract, most commonly from stomach ulceration. This also requires prompt veterinary attention.

Morning vomiting. Many CKD cats vomit first thing in the morning or overnight. The most likely explanation is that an empty stomach over the long gap since the last meal allows gastric secretions to accumulate and irritate the stomach lining. Feeding a small meal just before bedtime, or using an automated timed feeder to provide food during the night, often reduces this pattern significantly.

Vomiting immediately after eating. A cat who vomits within minutes of finishing a meal may have a gastric motility problem rather than simple uremia-driven vomiting. This is worth flagging to your vet as the treatment approach may differ.

Vomiting after subcutaneous fluids. A small number of cats vomit consistently after receiving subcutaneous fluids at home. This can sometimes be related to the type of fluid being used. If your cat regularly vomits after fluids, let your vet know so the fluid type or rate can be reviewed.

Chronic low-level vomiting. Some CKD cats vomit one to three times a week more or less indefinitely without it appearing to cause immediate distress. This still warrants treatment: chronic vomiting increases the risk of dehydration, causes discomfort even when not obviously acute, and is a sign that the underlying uremia is not well controlled.

Not all vomiting in a CKD cat is caused by uremia. Several other conditions produce the same symptom and are worth identifying and treating, as the treatments differ.

• High phosphorus levels. Elevated phosphorus contributes to how unwell the cat feels generally and can drive vomiting. Controlling phosphorus often produces noticeable improvement.
• Pancreatitis. Very common in cats and frequently concurrent with CKD. Pancreatitis causes significant nausea and vomiting and may require its own treatment alongside CKD management.
• Metabolic acidosis. A build-up of acid in the blood due to impaired kidney function can cause nausea and vomiting.
• Constipation. Some cats vomit before, during, or just after using the litter tray when severely constipated. If the timing of vomiting correlates with litter box visits, constipation is worth investigating.
• Inflammatory bowel disease (IBD). IBD can coexist with CKD and is a common cause of chronic vomiting in cats. If vomiting persists despite good uremia control, IBD should be considered.
• Hyperthyroidism medication. Methimazole and carbimazole, used to treat hyperthyroidism, cause vomiting in some cats. If your cat is on one of these, timing of vomiting relative to medication may be informative.
• Antibiotics. Some antibiotics, particularly those in the cephalosporin family, can cause nausea or vomiting. If vomiting started or worsened shortly after beginning a new antibiotic, mention this to your vet.
• Dehydration. Poorly hydrated cats feel more uremic and vomit more. Improving hydration through subcutaneous fluid therapy often reduces vomiting frequency directly.

Vomiting in CKD cats should always be mentioned at your next appointment, but some situations require prompt contact rather than waiting.

Contact your vet the same day or as an emergency if your cat:

• Has blood in the vomit, whether fresh red blood or dark coffee-ground material
• Is vomiting repeatedly and cannot keep any water down
• Appears weak, wobbly, or is unable to stand normally
• Has not eaten for 24 to 48 hours alongside vomiting
• Is showing signs of significant distress or pain

Cats who vomit frequently become dehydrated more quickly than healthy cats, and dehydration worsens the uremic toxin load, which in turn worsens vomiting. This cycle can escalate rapidly in a cat who is already compromised.

Several straightforward changes can reduce vomiting before or alongside medication.

Raise the food and water bowls. When a cat eats from a bowl on the floor, the stomach sits above the level of the esophagus junction, which can allow stomach contents to travel upward. Raising the bowl to around 15 cm (6 inches) off the ground reverses this, keeping the stomach lower and reducing reflux. Many owners notice a reduction in vomiting within a few days of making this change.

Feed small meals more often. An empty stomach is more likely to produce vomiting, particularly of foam or bile. Offering several small meals throughout the day keeps something in the stomach to absorb gastric secretions. A small meal just before bedtime specifically targets the overnight gap that causes morning vomiting.

Feed before bedtime and consider a timed feeder. If your cat tends to vomit overnight or first thing in the morning, a programmable feeder set to dispense a small portion during the night can interrupt the pattern. This is worth trying before adding medication if the vomiting is predominantly morning-pattern.

Warm wet food slightly. Warming food to just below body temperature can make it more aromatic and appealing, which helps in cats whose appetite is suppressed. It also reduces the chance of cold food causing stomach discomfort. Do not overheat, and always check for hot spots if using a microwave.

Slippery elm bark. This herbal supplement coats and soothes the lining of the digestive tract and is used by some owners to reduce vomiting and gastric discomfort. It is generally considered safe but can affect the absorption of other medications if given at the same time. Inform your vet before using it.

If home measures are not sufficient, medication is often highly effective and can produce a visible improvement within days. The IRIS 2023 treatment guidelines recommend treating vomiting and nausea in CKD cats with an antiemetic such as maropitant or ondansetron. The ISFM consensus guidelines state that vomiting should be actively managed in CKD cats and that centrally acting antiemetics such as maropitant and ondansetron should be considered.

Maropitant (Cerenia)

Maropitant works by blocking neurokinin-1 (NK-1) receptors in the chemoreceptor trigger zone and vomiting center of the brain. Because this is the same region stimulated by uremic toxins, maropitant is a particularly well-targeted choice for CKD-related vomiting. It also acts on NK-1 receptors in the gastrointestinal tract itself.

A randomized, blinded, placebo-controlled clinical trial specifically in CKD cats found a significant reduction in vomiting frequency with maropitant compared to placebo. Maropitant may also have mild anti-inflammatory and pain-modifying properties, which may be an additional benefit in cats with concurrent pancreatitis.

Maropitant is given once daily, which is a practical advantage for long-term use. It is available as tablets (16 mg, typically given at approximately 1 mg/kg per day, so around a quarter of a tablet for a 4 to 4.5 kg cat) and as an injectable solution. The injectable form is approved for use in cats and is the form validated in clinical studies; the tablet is used off-label but is commonly prescribed and effective.

Injectable maropitant stings on administration. Keeping the vial in the fridge beforehand, and injecting into the fluid pocket after giving subcutaneous fluids, both help reduce discomfort. Prevomax and Vetemex, newer injectable formulations available in the UK and Europe, contain a preservative that reduces injection site pain. Elmaro is a more recent addition available in the UK as of 2025.

One important interaction: the European Medicines Agency advises against combining maropitant with calcium channel blockers such as amlodipine, which is commonly prescribed in CKD cats for hypertension. If your cat takes amlodipine, discuss timing with your vet. Separating the two medications by 12 hours appears to reduce the risk of interaction.

On long-term use. The original manufacturer guidance recommended breaks in maropitant treatment, based on concerns about dopamine effects with extended use in dogs. More recently, Colorado State University’s Quimby lab gave maropitant daily for 14 days to CKD cats in a clinical trial without significant adverse effects and has indicated willingness to prescribe it continuously. A pharmacokinetic and toxicity study also gave maropitant to cats for 15 consecutive days without apparent problems, though one cat had minor sleep tremors. Many vets now use maropitant continuously in CKD cats. Monitor for tremors or shaking and discuss the approach with your vet.

Ondansetron (Zofran)

Ondansetron works through a different mechanism, selectively blocking serotonin 5-HT3 receptors. Because it acts at a different point in the vomiting pathway from maropitant, the two can complement each other. Some cats respond better to one than the other, and for cats whose vomiting is not adequately controlled by maropitant alone, adding or switching to ondansetron is a reasonable next step.

Ondansetron has been used in human CKD patients for uremic nausea and vomiting for decades and was first used in CKD cats in the early 2000s. Since generic versions became available, it has become steadily more common in feline CKD management. A 2025 study confirmed its efficacy in controlling vomiting in cats, with comparable results to maropitant in that model.

Formulations. Ondansetron is available as tablets (4 mg or 8 mg), as an injectable solution, and as a transdermal gel. Oral bioavailability varies widely between individual cats, from around 11% to 50% in one pharmacokinetic study. Injectable or subcutaneous administration is more reliable and produces faster results. The transdermal gel has been found not to achieve clinically relevant blood concentrations and is generally not recommended, though some owners report finding it helpful.

Injectable ondansetron stings on administration, but less so if given after subcutaneous fluids. It works quickly; most cats show a response within one to two hours.

Dosing. A commonly used starting dose is 1 mg, given twice daily. Because the half-life is short in cats (roughly one hour), twice-daily dosing may not maintain adequate levels throughout the day. If twice-daily dosing is not providing enough control, the ISFM guidelines recommend dosing every six to eight hours rather than increasing the dose first. Individual cats vary considerably in how they metabolize ondansetron, so some experimentation in frequency is normal.

Ondansetron is considered safe to use in cats with kidney disease without dose reduction; no adjustment is needed for CKD itself, though cats with significant liver disease may need lower doses or longer intervals.

Interactions. Ondansetron and mirtazapine (sometimes used as an appetite stimulant in CKD cats) share serotonin pathways, and combining them may theoretically increase the risk of serotonin syndrome. If both are used, separating them by at least two hours is the general guidance. Ondansetron used alongside famotidine may increase the risk of cardiac arrhythmias in rare cases; this is worth mentioning to your vet if famotidine is also being considered. Ondansetron may also reduce the painkilling effect of tramadol if that is being used for pain management.

Choosing between them

Both drugs are endorsed by IRIS and ISFM for vomiting in CKD cats and both target the chemoreceptor trigger zone. Maropitant has the advantage of once-daily dosing and has a CKD-specific clinical trial supporting its use. Ondansetron may be preferable when vomiting is more severe, more acute, or when pancreatitis is suspected alongside CKD. When one is not providing adequate control, it is worth trying the other, or using both, before concluding that the vomiting is not medication-responsive.

Famotidine (Pepcid AC) and omeprazole are acid-suppressing medications that were routinely recommended for CKD cats for many years, based on the assumption that excess stomach acid was driving vomiting and nausea. As described above, the evidence for gastric hyperacidity in CKD cats is now much weaker than it once appeared.

Current guidance from the ACVIM states there is no evidence to support the routine use of gastroprotectants in cats with IRIS Stage 1 to 3 CKD, and that more data is needed for Stage 4. A 2023 study found that 60% of hospitalized cats given gastroprotectants had no valid medical reason for receiving them.

This does not mean these medications are useless in CKD cats. Some cats do appear to benefit from famotidine or omeprazole, and they may be appropriate if there is evidence of gastrointestinal bleeding or if a cat’s vomiting has not responded to antiemetics. However, they are no longer the automatic first step they once were, and many vets now reach for maropitant or ondansetron first.

If your vet suggests a gastroprotectant, it is reasonable to ask whether an antiemetic should also be considered, since the two work through entirely different mechanisms.

• IRIS treatment recommendations for CKD in cats (2023). International Renal Interest Society.
• ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease (2016). Sparkes AH et al. Journal of Feline Medicine and Surgery 18, pp219-239.
• Treatment of vomiting, nausea and inappetence in cats with chronic kidney disease. IRIS (iris-kidney.com).
• Quimby JM et al. (2015). Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial. Journal of Feline Medicine and Surgery 17(8), pp692-697.
• Quimby JM et al. (2014). Oral, subcutaneous and intravenous pharmacokinetics of ondansetron in healthy cats. Journal of Veterinary Pharmacology and Therapeutics 37(4), pp348-353.
• McLeland SM et al. (2014). Relationship among serum creatinine, serum gastrin, calcium-phosphorus product, and uremic gastropathy in cats with chronic kidney disease. Journal of Veterinary Internal Medicine 28(3), pp827-37.
• Tolbert MK et al. (2017). Evaluation of gastric pH and serum gastrin concentrations in cats with chronic kidney disease. Journal of Veterinary Internal Medicine 31(5), pp1414-1419.
• ACVIM consensus statement: support for rational administration of gastrointestinal protectants to dogs and cats (2018). Marks SL et al. Journal of Veterinary Internal Medicine 32(6), pp1823-1840.
• Evaluation of gastroprotectant administration in hospitalized cats in a tertiary referral hospital (2023). Ullal TV et al. Journal of Feline Medicine and Surgery 25(10).
• Gölgeli Bedir A et al. (2025). The effect of maropitant, ondansetron and metoclopramide on dexmedetomidine-induced vomiting in cats. Veterinary Medicine and Science 11(1).
• De Santis F et al. (2022). Drug-dosing adjustment in dogs and cats with chronic kidney disease. Animals (Basel).
• Hickman MA et al. (2008). Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats. Journal of Veterinary Pharmacology and Therapeutics 31(3), pp220-9.